What is Cheyne-Stokes breathing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Cheyne-Stokes Breathing?

Cheyne-Stokes breathing is an abnormal respiratory pattern characterized by episodes of at least 3 consecutive central apneas and/or central hypopneas separated by a crescendo-decrescendo change in breathing amplitude, with cycle lengths typically ranging from 45 to 90 seconds. 1

Formal Diagnostic Criteria

The American Academy of Sleep Medicine defines Cheyne-Stokes breathing when both of the following are met: 1

  • At least 3 consecutive central apneas and/or central hypopneas separated by crescendo-decrescendo breathing with a cycle length of at least 40 seconds (typically 45-90 seconds) 1
  • 5 or more central apneas and/or central hypopneas per hour associated with this pattern, recorded over a minimum of 2 hours of monitoring 1

The duration of Cheyne-Stokes breathing (absolute time or percentage of total sleep time) should be documented in sleep study reports. 1

The Breathing Pattern Explained

The pattern consists of: 2, 3

  • Periods of apnea or hypopnea (no breathing or reduced breathing)
  • Followed by gradually increasing tidal volume (crescendo phase)
  • Then gradually decreasing tidal volume (decrescendo phase)
  • Returning to apnea/hypopnea, completing the cycle

This crescendo-decrescendo pattern represents compensation for changing levels of blood oxygen and carbon dioxide. 2

Cycle Length Characteristics

Cycle length varies with disease severity and helps distinguish Cheyne-Stokes breathing from other forms of periodic breathing: 1

  • Heart failure patients: Cycle length typically 45-90 seconds, with longer cycles correlating with worse left ventricular function 1
    • LVEF >50%: ~49 seconds
    • LVEF <20%: ~86 seconds 1
  • Primary central sleep apnea (without heart failure): Cycle length ~37 seconds 1
  • Narcotic-induced central apnea: Shorter cycle length, typically without true crescendo-decrescendo pattern 1

Primary Clinical Associations

Heart failure is the most common cause of Cheyne-Stokes breathing, occurring in approximately 40-50% of patients with moderate to severe congestive heart failure (left ventricular ejection fraction <40%). 3, 4

Other associated conditions include: 5, 6

  • Neurological disorders (particularly stroke) 5, 6
  • Atrial fibrillation 5, 6
  • Pulmonary hypertension 5, 6
  • Renal failure 5, 6

Pathophysiological Mechanisms

The underlying mechanisms involve: 3, 7

  • Increased CNS sensitivity to arterial PCO2 and PO2 changes (increased central controller gain) 3
  • Decreased total body stores of CO2 and O2, causing instability in arterial blood gas tensions 3
  • Prolonged circulatory time in heart failure patients 3
  • Hyperventilation-induced hypocapnia as an important determinant 3
  • Instability in feedback control of chemical regulation of breathing 7

The pattern occurs primarily during light sleep (stages N1 and N2) when breathing is under chemical control rather than voluntary control. 8, 6

Clinical Presentation

Patients may present with: 3, 9

  • Excessive daytime sleepiness 3
  • Paroxysmal nocturnal dyspnea 3
  • Insomnia 3
  • Snoring 3
  • Frequent nocturnal arousals with disrupted sleep 3
  • Oxygen desaturation 9
  • Cardiac arrhythmias 9
  • Changes in mental status 9

In many patients, the abnormal breathing pattern may not be recognized, and clinical features are dominated by the underlying disease process. 9

Prognostic Significance

Cheyne-Stokes breathing carries important prognostic implications in heart failure: 1, 5

  • Central apnea-hypopnea index >30/hour is associated with poor survival in heart failure patients 1, 5
  • Longer duration of Cheyne-Stokes breathing correlates with higher mortality and elevated NT-proBNP (a marker of poor cardiac function) 1, 5
  • Mortality is increased compared to heart failure patients without Cheyne-Stokes breathing at similar levels of left ventricular dysfunction 3

The presence of Cheyne-Stokes breathing may reflect unrecognized congestive heart failure and is a risk factor for early mortality or need for heart transplant. 1, 5

Recognition in Clinical Practice

Cheyne-Stokes breathing may be observed as an irregular or periodic breathing pattern on physical examination in patients with acute decompensated heart failure. 1

The American College of Cardiology/American Heart Association lists Cheyne-Stokes respirations among physical findings that may support the diagnosis of heart failure, though it is not included in the required diagnostic criteria. 1

Management Approach

The primary intervention is optimizing guideline-based heart failure therapy, as Cheyne-Stokes breathing often improves with effective treatment of the underlying heart failure. 5, 8

Additional considerations: 8, 3, 9

  • Avoid interventions specifically aimed at suppressing the breathing pattern after heart failure therapy has been optimized, as it may be a compensatory mechanism 8
  • Nocturnal oxygen therapy may be considered 3, 9
  • Nasal continuous positive airway pressure may be considered 3, 9
  • Adaptive servo-ventilation is contraindicated in heart failure patients with reduced ejection fraction due to increased mortality risk 8, 6

Critical Pitfall to Avoid

Do not confuse Cheyne-Stokes breathing with other forms of periodic breathing. The key distinguishing features are: 1

  • Minimum cycle length of 40 seconds (typically 45-90 seconds in heart failure)
  • True crescendo-decrescendo pattern between apneas/hypopneas
  • At least 3 consecutive cycles meeting these criteria

Primary central sleep apnea and narcotic-induced central apnea have shorter cycle lengths (~26-37 seconds) and typically lack the true crescendo-decrescendo pattern. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cheyne-Stokes Breathing: Clinical Significance and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Central Sleep Apnea Beyond Heart Failure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Causes of Cheyne-Stokes respiration.

Neurocritical care, 2005

Guideline

Permissive Hypercapnia in Heart Failure Patients with Cheyne-Stokes Breathing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cheyne-Stokes respiration in congestive heart failure.

The Yale journal of biology and medicine, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.